{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:55:11Z","timestamp":1787896511445,"version":"build-2784847793"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["NWO #015.01.076"],"award-info":[{"award-number":["NWO #015.01.076"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001722","name":"Koninklijke Nederlandse Akademie van Wetenschappen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10571-018-0614-5","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T05:23:39Z","timestamp":1535779419000},"page":"503-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Resetting the Stress System with a Mifepristone Challenge"],"prefix":"10.1007","volume":"39","author":[{"given":"Sergiu","family":"Dalm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan M.","family":"Karssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno C.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Belanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ronald","family":"de Kloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nlm.2016.05.009","volume":"133","author":"JM Arp","year":"2016","unstructured":"Arp JM, ter Horst JP, Loi M et al (2016) Blocking glucocorticoid receptors at adolescent age prevents enhanced freezing between repeated cue-exposures after conditioned fear in adult mice raised under chronic early life stress. Neurobiol Learn Mem 133:30\u201338. \n                    https:\/\/doi.org\/10.1016\/j.nlm.2016.05.009","journal-title":"Neurobiol Learn Mem"},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1210\/en.2015-1390","volume":"156","author":"E Atucha","year":"2015","unstructured":"Atucha E, Zalachoras I, van den Heuvel JK et al (2015) A mixed glucocorticoid\/mineralocorticoid selective modulator with dominant antagonism in the male rat brain. Endocrinology 156:4105\u20134114. \n                    https:\/\/doi.org\/10.1210\/en.2015-1390","journal-title":"Endocrinology"},{"key":"614_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.npp.1300158","volume":"28","author":"CG Bachmann","year":"2003","unstructured":"Bachmann CG, Linthorst ACE, Holsboer F, Reul JMHM (2003) Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis. Neuropsychopharmacology 28:1056\u20131067. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1300158","journal-title":"Neuropsychopharmacology"},{"key":"614_CR4","doi-asserted-by":"publisher","first-page":"e91248","DOI":"10.1371\/journal.pone.0091248","volume":"9","author":"JL Beaudry","year":"2014","unstructured":"Beaudry JL, Dunford EC, Teich T et al (2014) Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats. PLoS ONE 9:e91248. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0091248","journal-title":"PLoS ONE"},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","volume":"21","author":"JK Belanoff","year":"2001","unstructured":"Belanoff JK, Flores BH, Kalezhan M et al (2001) Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 21:516\u2013521. \n                    https:\/\/doi.org\/10.1097\/00004714-200110000-00009","journal-title":"J Clin Psychopharmacol"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0006-3223(02)01432-4","volume":"52","author":"JK Belanoff","year":"2002","unstructured":"Belanoff JK, Rothschild AJ, Cassidy F et al (2002) An open label trial of C-1073 (mifepristone) for psychotic major depression*. Biol Psychiatr 52:386\u2013392. \n                    https:\/\/doi.org\/10.1016\/S0006-3223(02)01432-4","journal-title":"Biol Psychiatr"},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cct.2009.03.001","volume":"30","author":"CM Blasey","year":"2009","unstructured":"Blasey CM, Debattista C, Roe R et al (2009) A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction. Contemp Clin Trials 30:284\u2013288. \n                    https:\/\/doi.org\/10.1016\/j.cct.2009.03.001","journal-title":"Contemp Clin Trials"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/JCP.0b013e3182239191","volume":"31","author":"CM Blasey","year":"2011","unstructured":"Blasey CM, Block TS, Belanoff JK, Roe RL (2011) Efficacy and safety of mifepristone for the treatment of psychotic depression. J Clin Psychopharmacol 31:436\u2013440. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e3182239191","journal-title":"J Clin Psychopharmacol"},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/JCP.0000000000000744","volume":"37","author":"T Block","year":"2017","unstructured":"Block T, Petrides G, Kushner H et al (2017) Mifepristone plasma level and glucocorticoid receptor antagonism associated with response in patients with psychotic depression. J Clin Psychopharmacol 37:505\u2013511. \n                    https:\/\/doi.org\/10.1097\/JCP.0000000000000744","journal-title":"J Clin Psychopharmacol"},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopsych.2018.01.008","volume":"84","author":"TS Block","year":"2018","unstructured":"Block TS, Kushner H, Kalin N et al (2018) Combined analysis of mifepristone for psychotic depression: plasma levels associated with clinical response. Biol Psychiatr 84:46\u201354. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2018.01.008","journal-title":"Biol Psychiatr"},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3758\/BF03200795","volume":"32","author":"S Dalm","year":"2000","unstructured":"Dalm S, Grootendorst J, R de KE SOM (2000) Quantification of swim patterns in the Morris water maze. Behav Res Methods Instrum Comput. 32:134\u2013139","journal-title":"Behav Res Methods Instrum Comput."},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000089555","volume":"81","author":"S Dalm","year":"2005","unstructured":"Dalm S, Enthoven L, Meijer OC et al (2005) Age-related changes in hypothalamic-pituitary-adrenal axis activity of male C57BL\/6J mice. Neuroendocrinology 81:372\u2013380. \n                    https:\/\/doi.org\/10.1159\/000089555","journal-title":"Neuroendocrinology"},{"key":"614_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneumeth.2007.12.021","volume":"170","author":"S Dalm","year":"2008","unstructured":"Dalm S, Brinks V, van der Mark MH et al (2008) Non-invasive stress-free application of glucocorticoid ligands in mice. J Neurosci Methods 170:77\u201384. \n                    https:\/\/doi.org\/10.1016\/j.jneumeth.2007.12.021","journal-title":"J Neurosci Methods"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/hipo.20905","volume":"22","author":"NA Datson","year":"2012","unstructured":"Datson NA, Speksnijder N, Mayer JL et al (2012) The transcriptional response to chronic stress and glucocorticoid receptor blockade in the hippocampal dentate gyrus. Hippocampus 22:359\u2013371. \n                    https:\/\/doi.org\/10.1002\/hipo.20905","journal-title":"Hippocampus"},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"3261--3272","DOI":"10.1210\/en.2012-2233","volume":"154","author":"NA Datson","year":"2013","unstructured":"Datson NA, van den Oever JME, Korobko OB et al (2013) Prior history of chronic stress changes the transcriptional response to glucocorticoid challenge in the dentate gyrus region of the male rat hippocampus. Endocrinology 154:3261--3272","journal-title":"Endocrinology"},{"key":"614_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/09614520701469617","volume":"12","author":"ER Kloet de","year":"1991","unstructured":"de Kloet ER (1991) Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12:95\u2013164. \n                    https:\/\/doi.org\/10.1080\/09614520701469617","journal-title":"Front Neuroendocrinol"},{"key":"614_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.physbeh.2016.12.045","volume":"178","author":"ER Kloet de","year":"2017","unstructured":"de Kloet ER, Jo\u00ebls M (2017) Brain mineralocorticoid receptor function in control of salt balance and stress-adaptation. Physiol Behav 178:13\u201320. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2016.12.045","journal-title":"Physiol Behav"},{"key":"614_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000124900","volume":"47","author":"ER Kloet de","year":"1988","unstructured":"de Kloet ER, De Kock S, Schild V, Veldhuis HD (1988) Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites. Neuroendocrinology 47:109\u2013115. \n                    https:\/\/doi.org\/10.1159\/000124900","journal-title":"Neuroendocrinology"},{"key":"614_CR19","first-page":"269","volume":"19","author":"ER Kloet De","year":"1998","unstructured":"De Kloet ER, Vreugdenhil E, Oitzl MS, Jo\u00ebls M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269\u2013301","journal-title":"Endocr Rev"},{"key":"614_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1210\/er.2002-0006","volume":"24","author":"K Bosscher De","year":"2003","unstructured":"De Bosscher K, Vanden Berghe W, Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488\u2013522","journal-title":"Endocr Rev"},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrn1683","volume":"6","author":"ER Kloet de","year":"2005","unstructured":"de Kloet ER, Jo\u00ebls M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463\u2013475. \n                    https:\/\/doi.org\/10.1038\/nrn1683","journal-title":"Nat Rev Neurosci"},{"key":"614_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2015.09.002","volume":"37","author":"K Bosscher De","year":"2016","unstructured":"De Bosscher K, Beck IM, Ratman D et al (2016) Activation of the glucocorticoid receptor in acute inflammation: the SEDIGRAM concept. Trends Pharmacol Sci 37:4\u201316. \n                    https:\/\/doi.org\/10.1016\/j.tips.2015.09.002","journal-title":"Trends Pharmacol Sci"},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.yfrne.2018.02.003","volume":"49","author":"ER Kloet de","year":"2018","unstructured":"de Kloet ER, Meijer OC, de Nicola AF et al (2018) Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation. Front Neuroendocrinol 49:124\u2013145. \n                    https:\/\/doi.org\/10.1016\/j.yfrne.2018.02.003","journal-title":"Front Neuroendocrinol"},{"key":"614_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tem.2006.02.006","volume":"17","author":"C DeBattista","year":"2006","unstructured":"DeBattista C, Belanoff J (2006) The use of mifepristone in the treatment of neuropsychiatric disorders. Trends Endocrinol Metab 17:117\u2013121. \n                    https:\/\/doi.org\/10.1016\/j.tem.2006.02.006","journal-title":"Trends Endocrinol Metab"},{"key":"614_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-4684-1242-0_9","volume-title":"The antiprogestin steroid RU 486 and human fertility control","author":"R Deraedt","year":"1985","unstructured":"Deraedt R, Bonnat C, Busigny M et al (1985) Pharmacokinetics of RU 486. In: The antiprogestin steroid RU 486 and human fertility control. Springer, Boston, pp\u00a0103\u2013122"},{"key":"614_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000054384","volume":"68","author":"M Deuschle","year":"1998","unstructured":"Deuschle M, Weber B, Colla M et al (1998) Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans. Neuroendocrinology 68:355\u2013360. \n                    https:\/\/doi.org\/10.1159\/000054384","journal-title":"Neuroendocrinology"},{"key":"614_CR27","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","volume":"23","author":"S Di","year":"2003","unstructured":"Di S, Malcher-Lopes R, Halmos KC, Tasker JG (2003) Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23:4850\u20134857","journal-title":"J Neurosci"},{"key":"614_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1159\/000126592","volume":"58","author":"C Dodt","year":"1993","unstructured":"Dodt C, Kern W, Fehm L, Born J (1993) Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 58:570\u2013574. \n                    https:\/\/doi.org\/10.1159\/000126592","journal-title":"Neuroendocrinology"},{"key":"614_CR29","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1523\/JNEUROSCI.1187-07.2007","volume":"27","author":"D Ferguson","year":"2007","unstructured":"Ferguson D, Sapolsky R (2007) Mineralocorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory. J Neurosci 27:8046\u20138052. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1187-07.2007","journal-title":"J Neurosci"},{"key":"614_CR30","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BMK, Findling JW et al (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97:2039\u20132049. \n                    https:\/\/doi.org\/10.1210\/jc.2011-3350","journal-title":"J Clin Endocrinol Metab"},{"key":"614_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.npp.1300884","volume":"31","author":"BH Flores","year":"2006","unstructured":"Flores BH, Kenna H, Keller J et al (2006) Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31:628\u2013636. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1300884","journal-title":"Neuropsychopharmacology"},{"key":"614_CR32","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.81.12.3879","volume":"81","author":"RC Gaillard","year":"1984","unstructured":"Gaillard RC, Riondel A, Muller AF et al (1984) RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci 81:3879\u20133882. \n                    https:\/\/doi.org\/10.1073\/pnas.81.12.3879","journal-title":"Proc Natl Acad Sci"},{"key":"614_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006995.pub2","author":"B Garner","year":"2016","unstructured":"Garner B, Phillips LJ, Bendall S, Hetrick SE (2016) Antiglucocorticoid and related treatments for psychosis. Cochrane Database Syst Rev \n                    https:\/\/doi.org\/10.1002\/14651858.CD006995.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"614_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.mce.2011.06.020","volume":"350","author":"FL Groeneweg","year":"2012","unstructured":"Groeneweg FL, Karst H, de Kloet ER, Jo\u00ebls M (2012) Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol 350:299\u2013309. \n                    https:\/\/doi.org\/10.1016\/j.mce.2011.06.020","journal-title":"Mol Cell Endocrinol"},{"key":"614_CR35","first-page":"3088","volume":"54","author":"DJ Gruol","year":"1994","unstructured":"Gruol DJ, Zee MC, Trotter J, Bourgeois S (1994) Reversal of multidrug resistance by RU 486. Cancer Res 54:3088\u20133091","journal-title":"Cancer Res"},{"key":"614_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.psyneuen.2012.08.007","volume":"38","author":"AP Harris","year":"2013","unstructured":"Harris AP, Holmes MC, de Kloet ER et al (2013) Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology 38:648\u2013658. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2012.08.007","journal-title":"Psychoneuroendocrinology"},{"key":"614_CR37","first-page":"R710","volume":"271","author":"PJ Havel","year":"1996","unstructured":"Havel PJ, Busch BL, Curry DL et al (1996) Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats. Am J Physiol 271:R710\u2013R717","journal-title":"Am J Physiol"},{"key":"614_CR38","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1002\/j.1460-2075.1994.tb06726.x","volume":"13","author":"S Heck","year":"1994","unstructured":"Heck S, Kullmann M, Gast A et al (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087\u20134095. \n                    https:\/\/doi.org\/10.1002\/j.1460-2075.1994.tb06726.x","journal-title":"EMBO J"},{"key":"614_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0022-4731(87)90083-5","volume":"26","author":"O Heikinheimo","year":"1987","unstructured":"Heikinheimo O, Kontula K, Croxatto H et al (1987) Plasma concentrations and receptor binding of RU 486 and its metabolites in humans. J Steroid Biochem 26:279\u2013284. \n                    https:\/\/doi.org\/10.1016\/0022-4731(87)90083-5","journal-title":"J Steroid Biochem"},{"key":"614_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","volume":"204","author":"MN Hill","year":"2012","unstructured":"Hill MN, Tasker JG (2012) Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 204:5\u201316. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2011.12.030","journal-title":"Neuroscience"},{"key":"614_CR41","doi-asserted-by":"publisher","first-page":"15486","DOI":"10.1073\/pnas.1512653112","volume":"112","author":"F Hollis","year":"2015","unstructured":"Hollis F, van der Kooij MA, Zanoletti O et al (2015) Mitochondrial function in the brain links anxiety with social subordination. Proc Natl Acad Sci 112:15486\u201315491. \n                    https:\/\/doi.org\/10.1073\/pnas.1512653112","journal-title":"Proc Natl Acad Sci"},{"key":"614_CR42","doi-asserted-by":"publisher","first-page":"e46224","DOI":"10.1371\/journal.pone.0046224","volume":"7","author":"P Hu","year":"2012","unstructured":"Hu P, Oomen C, van Dam A-M et al (2012) a single-day treatment with mifepristone is sufficient to normalize chronic glucocorticoid induced suppression of hippocampal cell proliferation. PLoS ONE 7:e46224. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0046224","journal-title":"PLoS ONE"},{"key":"614_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/1044-7431(91)90015-G","volume":"2","author":"T Iglesias","year":"1991","unstructured":"Iglesias T, Verbeeck MAE, De Kloet RE et al (1991) Time- and region-dependent effect of adrenalectomy on neuropeptide gene expression in rat hippocampus and striatum. Mol Cell Neurosci 2:485\u2013490. \n                    https:\/\/doi.org\/10.1016\/1044-7431(91)90015-G","journal-title":"Mol Cell Neurosci"},{"key":"614_CR44","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1210\/endo-124-5-2144","volume":"124","author":"L Jacobson","year":"1989","unstructured":"Jacobson L, Akana SF, Cascio CS et al (1989) The adrenocortical system responds slowly to removal of corticosterone in the absence of concurrent stress*. Endocrinology 124:2144\u20132152. \n                    https:\/\/doi.org\/10.1210\/endo-124-5-2144","journal-title":"Endocrinology"},{"key":"614_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tips.2006.03.007","volume":"27","author":"M Jo\u00ebls","year":"2006","unstructured":"Jo\u00ebls M (2006) Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci 27:244\u2013250. \n                    https:\/\/doi.org\/10.1016\/j.tips.2006.03.007","journal-title":"Trends Pharmacol Sci"},{"key":"614_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0166-2236(92)90345-9","volume":"15","author":"M Jo\u00ebls","year":"1992","unstructured":"Jo\u00ebls M, de Kloet ER (1992) Control of neuronal excitability by corticosteroid hormones. Trends Neurosci 15:25\u201330. \n                    https:\/\/doi.org\/10.1016\/0166-2236(92)90345-9","journal-title":"Trends Neurosci"},{"key":"614_CR47","doi-asserted-by":"publisher","first-page":"T49","DOI":"10.1530\/JOE-16-0660","volume":"234","author":"M Jo\u00ebls","year":"2017","unstructured":"Jo\u00ebls M, de Kloet ER (2017) 30 Years of the mineralocorticoid receptor: the brain mineralocorticoid receptor: a saga in three episodes. J Endocrinol 234:T49\u2013T66. \n                    https:\/\/doi.org\/10.1530\/JOE-16-0660","journal-title":"J Endocrinol"},{"key":"614_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tins.2007.10.005","volume":"31","author":"M Jo\u00ebls","year":"2008","unstructured":"Jo\u00ebls M, Karst H, DeRijk R, de Kloet ER (2008) The coming out of the brain mineralocorticoid receptor. Trends Neurosci 31:1\u20137. \n                    https:\/\/doi.org\/10.1016\/j.tins.2007.10.005","journal-title":"Trends Neurosci"},{"key":"614_CR49","doi-asserted-by":"publisher","first-page":"e13066","DOI":"10.1111\/apha.13066","volume":"223","author":"M Jo\u00ebls","year":"2018","unstructured":"Jo\u00ebls M, Karst H, Sarabdjitsingh RA (2018) The stressed brain of humans and rodents. Acta Physiol (Oxf) 223:e13066. \n                    https:\/\/doi.org\/10.1111\/apha.13066","journal-title":"Acta Physiol (Oxf)"},{"key":"614_CR50","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1210\/endo.142.6.8213","volume":"142","author":"AM Karssen","year":"2001","unstructured":"Karssen AM, Meijer OC, van der Sandt IC et al (2001) Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 142:2686\u20132694. \n                    https:\/\/doi.org\/10.1210\/endo.142.6.8213","journal-title":"Endocrinology"},{"key":"614_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1677\/joe.0.1750251","volume":"175","author":"AM Karssen","year":"2002","unstructured":"Karssen AM, Meijer OC, van der Sandt ICJ et al (2002) The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. J Endocrinol 175:251\u2013260. \n                    https:\/\/doi.org\/10.1677\/joe.0.1750251","journal-title":"J Endocrinol"},{"key":"614_CR52","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1196\/annals.1314.048","volume":"1032","author":"AM Karssen","year":"2004","unstructured":"Karssen AM, Meijer O, Pons D, de Kloet ER (2004) Localization of mRNA expression of p-glycoprotein at the blood-brain barrier and in the hippocampus. Ann N Y Acad Sci 1032:308\u2013311. \n                    https:\/\/doi.org\/10.1196\/annals.1314.048","journal-title":"Ann N Y Acad Sci"},{"key":"614_CR53","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1210\/en.2005-0501","volume":"146","author":"AM Karssen","year":"2005","unstructured":"Karssen AM, Meijer OC, Berry A et al (2005) Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology 146:5587\u20135595. \n                    https:\/\/doi.org\/10.1210\/en.2005-0501","journal-title":"Endocrinology"},{"key":"614_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1152\/jn.00691.2002","volume":"89","author":"H Karst","year":"2003","unstructured":"Karst H, Jo\u00ebls M (2003) Effect of chronic stress on synaptic currents in rat hippocampal dentate gyrus neurons. J Neurophysiol 89:625\u2013633. \n                    https:\/\/doi.org\/10.1152\/jn.00691.2002","journal-title":"J Neurophysiol"},{"key":"614_CR55","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.1073\/pnas.0507572102","volume":"102","author":"H Karst","year":"2005","unstructured":"Karst H, Berger S, Turiault M et al (2005) Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci 102:19204\u201319207. \n                    https:\/\/doi.org\/10.1073\/pnas.0507572102","journal-title":"Proc Natl Acad Sci"},{"key":"614_CR56","doi-asserted-by":"publisher","first-page":"14449","DOI":"10.1073\/pnas.0914381107","volume":"107","author":"H Karst","year":"2010","unstructured":"Karst H, Berger S, Erdmann G et al (2010) Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A 107:14449\u201314454. \n                    https:\/\/doi.org\/10.1073\/pnas.0914381107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"614_CR57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/10253890701821081","volume":"11","author":"BJ Kolber","year":"2008","unstructured":"Kolber BJ, Wieczorek L, Muglia LJ (2008) Hypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor function. Stress 11:321\u2013338. \n                    https:\/\/doi.org\/10.1080\/10253890701821081","journal-title":"Stress"},{"key":"614_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/en.2017-00512","volume":"159","author":"J Kroon","year":"2018","unstructured":"Kroon J, Koorneef LL, van den Heuvel JK et al (2018) Selective glucocorticoid receptor antagonist CORT125281 activates brown adipose tissue and alters lipid distribution in male mice. Endocrinology 159:535\u2013546. \n                    https:\/\/doi.org\/10.1210\/en.2017-00512","journal-title":"Endocrinology"},{"key":"614_CR59","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.1073\/pnas.0812062106","volume":"106","author":"S Lachize","year":"2009","unstructured":"Lachize S, Apostolakis EM, van der Laan S et al (2009) Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids. Proc Natl Acad Sci USA 106:8038\u20138042. \n                    https:\/\/doi.org\/10.1073\/pnas.0812062106","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR60","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0022-4731(87)90160-9","volume":"27","author":"P L\u00e4hteenm\u00e4ki","year":"1987","unstructured":"L\u00e4hteenm\u00e4ki P, Heikinheimo O, Croxatto H et al (1987) Pharmacokinetics and metabolism of RU 486. J Steroid Biochem 27:859\u2013863","journal-title":"J Steroid Biochem"},{"key":"614_CR61","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/j.1460-9568.2007.05427.x","volume":"25","author":"M Lai","year":"2007","unstructured":"Lai M, Horsburgh K, Bae SE et al (2007) Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci 25:1832\u20131842. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05427.x","journal-title":"Eur J Neurosci"},{"key":"614_CR62","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0014-5793(94)01186-9","volume":"355","author":"V Lecureur","year":"1994","unstructured":"Lecureur V, Fardel O, Guillouzo A (1994) The antiprogestatin drug RU 486 potentiates doxorubicin cytotoxicity in multidrug resistant cells through inhibition of P-glycoprotein function. FEBS Lett 355:187\u2013191. \n                    https:\/\/doi.org\/10.1016\/0014-5793(94)01186-9","journal-title":"FEBS Lett"},{"key":"614_CR63","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0253-17.2017","author":"M Loi","year":"2017","unstructured":"Loi M, Sarabdjitsingh RA, Tsouli A et al (2017) Transient prepubertal mifepristone treatment normalizes deficits in contextual memory and neuronal activity of adult male rats exposed to maternal deprivation. Eneuro. \n                    https:\/\/doi.org\/10.1523\/ENEURO.0253-17.2017","journal-title":"Eneuro."},{"key":"614_CR64","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1365-2826.2012.02353.x","volume":"24","author":"BL Mason","year":"2012","unstructured":"Mason BL, Pariante CM, Thomas SA (2012) Changes in the brain accumulation of glucocorticoids in abcb1a-deficient CF-1 mice. J Neuroendocrinol 24:1440\u20131446. \n                    https:\/\/doi.org\/10.1111\/j.1365-2826.2012.02353.x","journal-title":"J Neuroendocrinol"},{"key":"614_CR65","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.biopsych.2018.01.021","volume":"83","author":"N Matosin","year":"2018","unstructured":"Matosin N, Halldorsdottir T, Binder EB (2018) Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: the FKBP5 model. Biol Psychiatr 83:821\u2013830. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2018.01.021","journal-title":"Biol Psychiatr"},{"key":"614_CR66","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1365-2826.2006.01455.x","volume":"18","author":"JL Mayer","year":"2006","unstructured":"Mayer JL, Klumpers L, Maslam S et al (2006) Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol 18:629\u2013631. \n                    https:\/\/doi.org\/10.1111\/j.1365-2826.2006.01455.x","journal-title":"J Neuroendocrinol"},{"key":"614_CR67","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1210\/endo.139.4.5917","volume":"139","author":"OC Meijer","year":"1998","unstructured":"Meijer OC, De Lange ECM, Breimer DD et al (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789\u20131793","journal-title":"Endocrinology"},{"key":"614_CR68","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1210\/endo.141.6.7489","volume":"141","author":"OC Meijer","year":"2000","unstructured":"Meijer OC, Steenbergen PJ, De Kloet ER (2000) Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 141:2192\u20132199. \n                    https:\/\/doi.org\/10.1210\/endo.141.6.7489","journal-title":"Endocrinology"},{"key":"614_CR69","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1210\/en.2004-0411","volume":"146","author":"OC Meijer","year":"2005","unstructured":"Meijer OC, Kalkhoven E, van der Laan S et al (2005) Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 146:1438\u20131448. \n                    https:\/\/doi.org\/10.1210\/en.2004-0411","journal-title":"Endocrinology"},{"key":"614_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ando.2018.03.004","volume":"79","author":"OC Meijer","year":"2018","unstructured":"Meijer OC, Koorneef LL, Kroon J (2018) Glucocorticoid receptor modulators. Ann Endocrinol (Paris) 79:107\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.ando.2018.03.004","journal-title":"Ann Endocrinol (Paris)"},{"key":"614_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jsbmb.2014.02.007","volume":"143","author":"M Meyer","year":"2014","unstructured":"Meyer M, Gonzalez Deniselle MC, Hunt H et al (2014) The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice. J Steroid Biochem Mol Biol 143:40\u201348. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2014.02.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"614_CR72","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuroscience.2018.05.042","volume":"384","author":"M Meyer","year":"2018","unstructured":"Meyer M, Lara A, Hunt H et al (2018) The selective glucocorticoid receptor modulator cort 113176 reduces neurodegeneration and neuroinflammation in wobbler mice spinal cord. Neuroscience 384:384\u2013396. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2018.05.042","journal-title":"Neuroscience"},{"key":"614_CR73","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1073\/pnas.1605246113","volume":"113","author":"KR Mifsud","year":"2016","unstructured":"Mifsud KR, Reul JMHM (2016) Acute stress enhances heterodimerization and binding of corticosteroid receptors at glucocorticoid target genes in the hippocampus. Proc Natl Acad Sci U S A 113:11336\u201311341. \n                    https:\/\/doi.org\/10.1073\/pnas.1605246113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"614_CR74","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jsbmb.2016.03.023","volume":"165","author":"AG Moraitis","year":"2017","unstructured":"Moraitis AG, Block T, Nguyen D, Belanoff JK (2017) The role of glucocorticoid receptors in metabolic syndrome and psychiatric illness. J Steroid Biochem Mol Biol 165:114\u2013120. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.023","journal-title":"J Steroid Biochem Mol Biol"},{"key":"614_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/edrv-5-1-25","volume":"5","author":"A Munck","year":"1984","unstructured":"Munck A, Guyre PM, Holbrook NJ (1984) Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5:25\u201344. \n                    https:\/\/doi.org\/10.1210\/edrv-5-1-25","journal-title":"Endocr Rev"},{"key":"614_CR76","first-page":"209","volume":"18","author":"BE Murphy","year":"1993","unstructured":"Murphy BE, Filipini D, Ghadirian AM (1993) Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci 18:209\u2013213","journal-title":"J Psychiatry Neurosci"},{"key":"614_CR77","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.physbeh.2017.01.020","volume":"178","author":"ET Nguyen","year":"2017","unstructured":"Nguyen ET, Streicher J, Berman S et al (2017) A mixed glucocorticoid\/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats. Physiol Behav 178:82\u201392. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2017.01.020","journal-title":"Physiol Behav"},{"key":"614_CR78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2017.08.045","volume":"336","author":"ET Nguyen","year":"2018","unstructured":"Nguyen ET, Caldwell JL, Streicher J et al (2018) Differential effects of imipramine and CORT118335 (glucocorticoid receptor modulator\/mineralocorticoid receptor antagonist) on brain-endocrine stress responses and depression-like behavior in female rats. Behav Brain Res 336:99\u2013110. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2017.08.045","journal-title":"Behav Brain Res"},{"key":"614_CR79","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1037\/0735-7044.106.1.62","volume":"106","author":"MS Oitzl","year":"1992","unstructured":"Oitzl MS, de Kloet ER (1992) Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 106:62\u201371. \n                    https:\/\/doi.org\/10.1037\/0735-7044.106.1.62","journal-title":"Behav Neurosci"},{"key":"614_CR80","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1460-9568.1994.tb00604.x","volume":"6","author":"MS Oitzl","year":"1994","unstructured":"Oitzl MS, Fluttert M, Ron de Kloet E (1994) The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur J Neurosci 6:1072\u20131079. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.1994.tb00604.x","journal-title":"Eur J Neurosci"},{"key":"614_CR81","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0306-4530(95)00003-7","volume":"20","author":"MS Oitzl","year":"1995","unstructured":"Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER (1995) Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 20:655\u2013675. \n                    https:\/\/doi.org\/10.1016\/0306-4530(95)00003-7","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 1","key":"614_CR82","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/S0306-4530(97)00020-6","volume":"22","author":"MS Oitzl","year":"1997","unstructured":"Oitzl MS, van Haarst AD, de Kloet ER (1997) Behavioral and neuroendocrine responses controlled by the concerted action of central mineralocorticoid (MRS) and glucocorticoid receptors (GRS). Psychoneuroendocrinology 22(Suppl 1):S87\u2013S93. \n                    https:\/\/doi.org\/10.1016\/S0306-4530(97)00020-6","journal-title":"Psychoneuroendocrinology"},{"key":"614_CR83","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1046\/j.1460-9568.1998.00381.x","volume":"10","author":"MS Oitzl","year":"1998","unstructured":"Oitzl MS, Fluttert M, Sutanto W, de Kloet ER (1998) Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur J Neurosci 10:3759\u20133766. \n                    https:\/\/doi.org\/10.1046\/j.1460-9568.1998.00381.x","journal-title":"Eur J Neurosci"},{"key":"614_CR84","doi-asserted-by":"publisher","first-page":"12790","DOI":"10.1073\/pnas.231313998","volume":"98","author":"MS Oitzl","year":"2001","unstructured":"Oitzl MS, Reichardt HM, Jo\u00ebls M, de Kloet ER (2001) Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci U S A 98:12790\u201312795. \n                    https:\/\/doi.org\/10.1073\/pnas.231313998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"614_CR85","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1111\/j.1460-9568.2007.05972.x","volume":"26","author":"CA Oomen","year":"2007","unstructured":"Oomen CA, Mayer JL, de Kloet ER et al (2007) Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur J Neurosci 26:3395\u20133401. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05972.x","journal-title":"Eur J Neurosci"},{"key":"614_CR86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrendo.2014.22","volume":"10","author":"M Picard","year":"2014","unstructured":"Picard M, Juster R-P, McEwen BS (2014) Mitochondrial allostatic load puts the \u2018gluc\u2019 back in glucocorticoids. Nat Rev Endocrinol 10:303\u2013310. \n                    https:\/\/doi.org\/10.1038\/nrendo.2014.22","journal-title":"Nat Rev Endocrinol"},{"key":"614_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2016.05.018","volume":"45","author":"F Pineau","year":"2016","unstructured":"Pineau F, Canet G, Desrumaux C et al (2016) New selective glucocorticoid receptor modulators reverse amyloid-\u03b2 peptide-induced hippocampus toxicity. Neurobiol Aging 45:109\u2013122","journal-title":"Neurobiol Aging"},{"key":"614_CR88","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000125046","volume":"48","author":"A Ratka","year":"1988","unstructured":"Ratka A, Sutanto W, De Kloet R (1988) Long-lasting glucocorticoid suppression of opioid-induced antinociception. Neuroendocrinology 48:439\u2013444. \n                    https:\/\/doi.org\/10.1159\/000125046","journal-title":"Neuroendocrinology"},{"key":"614_CR89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000125210","volume":"50","author":"A Ratka","year":"1989","unstructured":"Ratka A, Sutanto W, Bloemers M, de Kloet ER (1989) On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50:117\u2013123. \n                    https:\/\/doi.org\/10.1159\/000125210","journal-title":"Neuroendocrinology"},{"key":"614_CR90","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","volume":"93","author":"HM Reichardt","year":"1998","unstructured":"Reichardt HM, Kaestner KH, Tuckermann J et al (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531\u2013541. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(00)81183-6","journal-title":"Cell"},{"key":"614_CR91","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13059-015-0593-5","volume":"16","author":"V Repunte-Canonigo","year":"2015","unstructured":"Repunte-Canonigo V, Shin W, Vendruscolo LF et al (2015) Identifying candidate drivers of alcohol dependence-induced excessive drinking by assembly and interrogation of brain-specific regulatory networks. Genome Biol 16:68. \n                    https:\/\/doi.org\/10.1186\/s13059-015-0593-5","journal-title":"Genome Biol"},{"key":"614_CR92","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1210\/endo-117-6-2505","volume":"117","author":"JM Reul","year":"1985","unstructured":"Reul JM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117:2505\u20132511. \n                    https:\/\/doi.org\/10.1210\/endo-117-6-2505","journal-title":"Endocrinology"},{"key":"614_CR93","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1210\/endo-127-2-907","volume":"127","author":"JM Reul","year":"1990","unstructured":"Reul JM, de Kloet ER, van Sluijs FJ et al (1990) Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology 127:907\u2013915. \n                    https:\/\/doi.org\/10.1210\/endo-127-2-907","journal-title":"Endocrinology"},{"key":"614_CR94","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/npp.2008.136","volume":"34","author":"Y Revsin","year":"2009","unstructured":"Revsin Y, Rekers NV, Louwe MC et al (2009) Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 34:747\u2013758. \n                    https:\/\/doi.org\/10.1038\/npp.2008.136","journal-title":"Neuropsychopharmacology"},{"key":"614_CR95","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mce.2008.10.008","volume":"299","author":"K Ronacher","year":"2009","unstructured":"Ronacher K, Hadley K, Avenant C et al (2009) Ligand-selective transactivation and transrepression via the glucocorticoid receptor: Role of cofactor interaction. Mol Cell Endocrinol 299:219\u2013231. \n                    https:\/\/doi.org\/10.1016\/j.mce.2008.10.008","journal-title":"Mol Cell Endocrinol"},{"key":"614_CR96","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1073\/pnas.0606067104","volume":"104","author":"AM Rozeboom","year":"2007","unstructured":"Rozeboom AM, Akil H, Seasholtz AF (2007) Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci 104:4688\u20134693. \n                    https:\/\/doi.org\/10.1073\/pnas.0606067104","journal-title":"Proc Natl Acad Sci"},{"key":"614_CR97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1210\/edrv.21.1.0389","volume":"21","author":"RM Sapolsky","year":"2000","unstructured":"Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55\u201389. \n                    https:\/\/doi.org\/10.1210\/edrv.21.1.0389","journal-title":"Endocr Rev"},{"key":"614_CR200","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0022-4731(86)90300-6","volume":"25","author":"A Sarrieau","year":"1986","unstructured":"Sarrieau A, Dussaillant M, Agid F et al (1986) Autoradiographic localization of glucocorticoid and progesterone binding sites in the human post-mortem brain. J Steroid Biochem 25:717\u2013721. \n                    https:\/\/doi.org\/10.1016\/0022-4731(86)90300-6","journal-title":"J Steroid Biochem"},{"key":"614_CR98","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"AH Schinkel","year":"1995","unstructured":"Schinkel AH, Wagenaar E, van Deemter L et al (1995) Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698\u20131705. \n                    https:\/\/doi.org\/10.1172\/JCI118214","journal-title":"J Clin Invest"},{"key":"614_CR99","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1210\/en.2008-1211","volume":"150","author":"MV Schmidt","year":"2009","unstructured":"Schmidt MV, Sterlemann V, Wagner K et al (2009) Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: Differential short- and long-term consequences. Endocrinology 150:2709\u20132716. \n                    https:\/\/doi.org\/10.1210\/en.2008-1211","journal-title":"Endocrinology"},{"key":"614_CR100","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1162\/jocn.2009.21278","volume":"22","author":"L Schwabe","year":"2010","unstructured":"Schwabe L, Sch\u00e4chinger H, de Kloet ER, Oitzl MS (2010) Corticosteroids operate as a switch between memory systems. J Cogn Neurosci 22:1362\u20131372. \n                    https:\/\/doi.org\/10.1162\/jocn.2009.21278","journal-title":"J Cogn Neurosci"},{"key":"614_CR101","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2013.06.001","volume":"74","author":"L Schwabe","year":"2013","unstructured":"Schwabe L, Tegenthoff M, H\u00f6ffken O, Wolf OT (2013) Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain. Biol Psychiatry 74:801\u2013808. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2013.06.001","journal-title":"Biol Psychiatry"},{"key":"614_CR102","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.yhbeh.2014.02.002","volume":"65","author":"MB Solomon","year":"2014","unstructured":"Solomon MB, Wulsin AC, Rice T et al (2014) The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test. Horm Behav 65:363\u2013371. \n                    https:\/\/doi.org\/10.1016\/j.yhbeh.2014.02.002","journal-title":"Horm Behav"},{"key":"614_CR103","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/mp.2015.196","volume":"21","author":"N Sousa","year":"2016","unstructured":"Sousa N (2016) The dynamics of the stress neuromatrix. Mol Psychiatry 21:302\u2013312. \n                    https:\/\/doi.org\/10.1038\/mp.2015.196","journal-title":"Mol Psychiatry"},{"key":"614_CR104","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1210\/en.139.6.2718","volume":"139","author":"RL Spencer","year":"1998","unstructured":"Spencer RL, Kim PJ, Kalman BA, Cole MA (1998) Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 139:2718\u20132726. \n                    https:\/\/doi.org\/10.1210\/en.139.6.2718","journal-title":"Endocrinology"},{"key":"614_CR105","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0269881109348175","volume":"25","author":"F Spiga","year":"2011","unstructured":"Spiga F, Knight DM, Droste SK et al (2011) Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding. J Psychopharmacol 25:211\u2013221. \n                    https:\/\/doi.org\/10.1177\/0269881109348175","journal-title":"J Psychopharmacol"},{"key":"614_CR106","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nn2055","volume":"11","author":"AM Stranahan","year":"2008","unstructured":"Stranahan AM, Arumugam TV, Cutler RG et al (2008) Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 11:309\u2013317. \n                    https:\/\/doi.org\/10.1038\/nn2055","journal-title":"Nat Neurosci"},{"key":"614_CR107","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1152\/ajpendo.00490.2015","volume":"311","author":"T Teich","year":"2016","unstructured":"Teich T, Dunford EC, Porras DP et al (2016) Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction. Am J Physiol Metab 311:E56\u2013E68. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00490.2015","journal-title":"Am J Physiol Metab"},{"key":"614_CR201","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrn2647","volume":"6","author":"YM Ulrich-Lai","year":"2009","unstructured":"Ulrich-Lai YM, Herman JP (2009) Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 6:397\u2013409. \n                    https:\/\/doi.org\/10.1038\/nrn2647","journal-title":"Nat Rev Neurosci"},{"key":"614_CR108","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11064-007-9518-3","volume":"33","author":"F Thomson","year":"2008","unstructured":"Thomson F, Craighead M (2008) Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem Res 33:691\u2013707. \n                    https:\/\/doi.org\/10.1007\/s11064-007-9518-3","journal-title":"Neurochem Res"},{"key":"614_CR109","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2826.2006.01472.x","volume":"18","author":"NG Gemert van","year":"2006","unstructured":"van Gemert NG, Jo\u00ebls M (2006) Effect of chronic stress and mifepristone treatment on voltage-dependent Ca 2 + currents in rat hippocampal dentate gyrus. J Neuroendocrinol 18:732\u2013741. \n                    https:\/\/doi.org\/10.1111\/j.1365-2826.2006.01472.x","journal-title":"J Neuroendocrinol"},{"key":"614_CR110","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1677\/joe.0.0880243","volume":"88","author":"AM Dijk van","year":"1981","unstructured":"van Dijk AM, van Wimersma Greidanus TB, Burbach JP et al (1981) Brain adrenocorticotrophin after adrenalectomy and sham-operation of rats. J Endocrinol 88:243\u2013253. \n                    https:\/\/doi.org\/10.1677\/joe.0.0880243","journal-title":"J Endocrinol"},{"key":"614_CR111","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0006-8993(87)91563-0","volume":"436","author":"JAM Eekelen van","year":"1987","unstructured":"van Eekelen JAM, Kiss JZ, Westphal HM, de Kloet ER (1987) Immunocytochemical study on the intracellular localization of the type 2 glucocorticoid receptor in the rat brain. Brain Res 436:120\u2013128. \n                    https:\/\/doi.org\/10.1016\/0006-8993(87)91563-0","journal-title":"Brain Res"},{"key":"614_CR112","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1210\/en.137.11.4935","volume":"137","author":"AD Haarst Van","year":"1996","unstructured":"Van Haarst AD, Oitzl MS, Workel JO, De Kloet ER (1996) Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 137:4935\u20134943. \n                    https:\/\/doi.org\/10.1210\/en.137.11.4935","journal-title":"Endocrinology"},{"key":"614_CR113","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1023\/A:1022010904600","volume":"22","author":"AD Haarst van","year":"1997","unstructured":"van Haarst AD, Oitzl MS, de Kloet ER (1997) Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res 22:1323\u20131328. \n                    https:\/\/doi.org\/10.1023\/A:1022010904600","journal-title":"Neurochem Res"},{"key":"614_CR114","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1210\/en.2016-1422","volume":"158","author":"LTCM Weert Van","year":"2017","unstructured":"Van Weert LTCM, Buurstede JC, Mahfouz A et al (2017) NeuroD factors discriminate mineralocorticoid from glucocorticoid receptor DNA binding in the male rat brain. Endocrinology 158:1511\u20131522. \n                    https:\/\/doi.org\/10.1210\/en.2016-1422","journal-title":"Endocrinology"},{"key":"614_CR115","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/bph.13477","volume":"173","author":"JK Heuvel van den","year":"2016","unstructured":"van den Heuvel JK, Boon MR, van Hengel I et al (2016) Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation. Br J Pharmacol 173:1793\u20131804. \n                    https:\/\/doi.org\/10.1111\/bph.13477","journal-title":"Br J Pharmacol"},{"key":"614_CR116","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9673(96)01004-7","volume":"762","author":"RA Hoeven van der","year":"1997","unstructured":"van der Hoeven RA, Hofte AJ, Frenay M et al (1997) Liquid chromatography-mass spectrometry with on-line solid-phase extraction by a restricted-access C18 precolumn for direct plasma and urine injection. J Chromatogr A 762:193\u2013200. \n                    https:\/\/doi.org\/10.1016\/S0021-9673(96)01004-7","journal-title":"J Chromatogr A"},{"key":"614_CR117","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-013-3176-8","volume":"230","author":"R Veen van der","year":"2013","unstructured":"van der Veen R, Boshuizen MCS, de Kloet ER (2013) Mifepristone treatment affects the response to repeated amphetamine injections, but does not attenuate the expression of sensitization. Psychopharmacology 230:547\u2013556. \n                    https:\/\/doi.org\/10.1007\/s00213-013-3176-8","journal-title":"Psychopharmacology"},{"key":"614_CR118","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1523\/JNEUROSCI.0069-12.2012","volume":"32","author":"LF Vendruscolo","year":"2012","unstructured":"Vendruscolo LF, Barbier E, Schlosburg JE et al (2012) Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci 32:7563\u20137571. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0069-12.2012","journal-title":"J Neurosci"},{"key":"614_CR119","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1172\/JCI79828","volume":"125","author":"LF Vendruscolo","year":"2015","unstructured":"Vendruscolo LF, Estey D, Goodell V et al (2015) Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J Clin Invest 125:3193\u20133197. \n                    https:\/\/doi.org\/10.1172\/JCI79828","journal-title":"J Clin Invest"},{"key":"614_CR120","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.psyneuen.2010.01.011","volume":"35","author":"AC Wulsin","year":"2010","unstructured":"Wulsin AC, Herman JP, Solomon MB (2010) Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress. Psychoneuroendocrinology 35:1100\u20131112. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2010.01.011","journal-title":"Psychoneuroendocrinology"},{"key":"614_CR121","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1210\/jcem.83.9.5077","volume":"83","author":"EA Young","year":"1998","unstructured":"Young EA, Lopez JF, Murphy-Weinberg V et al (1998) The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans 1. J Clin Endocrinol Metab 83:3339\u20133345. \n                    https:\/\/doi.org\/10.1210\/jcem.83.9.5077","journal-title":"J Clin Endocrinol Metab"},{"key":"614_CR122","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.1073\/pnas.1219411110","volume":"110","author":"I Zalachoras","year":"2013","unstructured":"Zalachoras I, Houtman R, Atucha E et al (2013) Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. Proc Natl Acad Sci USA 110:7910\u20137915. \n                    https:\/\/doi.org\/10.1073\/pnas.1219411110","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR123","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/mp.2016.16","volume":"21","author":"I Zalachoras","year":"2016","unstructured":"Zalachoras I, Verhoeve SL, Toonen LJ et al (2016) Isoform switching of steroid receptor co-activator-1 attenuates glucocorticoid-induced anxiogenic amygdala CRH expression. Mol Psychiatr 21:1733\u20131739. \n                    https:\/\/doi.org\/10.1038\/mp.2016.16","journal-title":"Mol Psychiatr"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-018-0614-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-018-0614-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-018-0614-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T09:41:35Z","timestamp":1569231695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-018-0614-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1007\/s10571-018-0614-5","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"15 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"SD and AMK report no conflict of interest. ERdK is on the Scientific Advisory Board of the DynaCorts Group and owns stock of Corcept Therapeutics. OCM receives funding from Corcept Therapeutics. JKB is an employee of Corcept Therapeutics, which develops novel GR ligands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}